| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.1 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |